Research Analysts Set Expectations for USNA FY2025 Earnings

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Equities researchers at Sidoti Csr boosted their FY2025 earnings estimates for shares of USANA Health Sciences in a research report issued on Wednesday, July 23rd. Sidoti Csr analyst A. Lebiedzinski now forecasts that the company will earn $2.62 per share for the year, up from their prior estimate of $2.61. The consensus estimate for USANA Health Sciences' current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences' Q1 2026 earnings at $0.80 EPS, Q2 2026 earnings at $0.77 EPS, Q3 2026 earnings at $0.85 EPS, Q4 2026 earnings at $0.98 EPS and FY2026 earnings at $3.40 EPS.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, topping analysts' consensus estimates of $0.54 by $0.20. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. The firm had revenue of $235.85 million for the quarter, compared to analysts' expectations of $225.20 million.

Separately, Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.

USANA Health Sciences Price Performance

USNA stock traded down $0.13 during midday trading on Thursday, reaching $31.97. 175,530 shares of the stock were exchanged, compared to its average volume of 137,350. USANA Health Sciences has a 52 week low of $23.10 and a 52 week high of $45.86. The company has a fifty day moving average price of $30.86 and a 200 day moving average price of $30.11. The stock has a market capitalization of $595.19 million, a PE ratio of 17.76, a P/E/G ratio of 1.02 and a beta of 0.64.

Insider Activity

In other news, COO Walter Noot sold 6,291 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO G Doug Iiekking sold 4,548 shares of USANA Health Sciences stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Insiders have sold a total of 12,013 shares of company stock worth $360,149 over the last ninety days. Company insiders own 0.63% of the company's stock.

Institutional Investors Weigh In On USANA Health Sciences

Institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. boosted its position in shares of USANA Health Sciences by 339.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock valued at $27,000 after purchasing an additional 771 shares in the last quarter. Versant Capital Management Inc lifted its stake in USANA Health Sciences by 542.5% in the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock valued at $31,000 after buying an additional 971 shares during the period. Parallel Advisors LLC boosted its holdings in shares of USANA Health Sciences by 8,141.2% during the 1st quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock worth $38,000 after buying an additional 1,384 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of USANA Health Sciences during the 4th quarter worth approximately $83,000. Finally, CWM LLC increased its stake in shares of USANA Health Sciences by 109.7% in the 2nd quarter. CWM LLC now owns 2,762 shares of the company's stock valued at $84,000 after acquiring an additional 1,445 shares in the last quarter. 54.25% of the stock is owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.